Enduro logo — Bioproduction at scale

Enduro

Bioproduction at scale

Founded 2019 Denmark Denmark 25 employees Series A Total: $14.29M Biotechnology

General Information

Company Name Enduro
Founded Year 2019
Location Denmark Denmark +1
Employees 25
Industries Biotechnology
Funding Stage Series A
Social

Get notified when Enduro moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Enduro

Enduro Genetics is a Denmark-based biotech startup with a mission to revolutionize large-scale fermentations. Founded in 2019, the company's slogan "Bioproduction at scale" encapsulates its focus on helping biotech companies enhance large-scale fermentations, enabling them to bring products to market cheaper and faster. One of its key offerings is the proprietary platform Enduro Sense, which reprograms cells to improve population heterogeneity and endurance of production. Enduro Genetics received a €1.82M grant investment on 05 October 2022 from The European Innovation Council, showcasing investor confidence in the company's innovative approach. With seamless integration and self-selecting technology, Enduro Sense holds the promise of revolutionizing bioproduction. The company's commitment to advancing biotechnology and fostering collaborations is evident in its invitation for inquiries to test Enduro Sense, encouraging interested parties to get in touch at [email protected] or visit their website.

Taxonomy: biotech startup, large-scale fermentations, bioproduction, proprietary platform, synthetic-biology technology, microbial cells, production optimization, bioproduction efficiency, cell reprogramming, biotech industry, green bioproduction, technology provider, fermentation enhancement, bioengineering, bioprocess development

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 5
Investor Investor Investor Investor
•••• ••••
03 Feb 2025
Grant •••••• 1
Investor
05 Oct 2022
Seed Round •••••• 1
Investor
07 Apr 2022
Pre Seed Round •••••• 1
Investor
02 Dec 2020

Enduro Alternatives & Competitors

Enduro vs
EryPharm
EryPharm France

EryPharm developed a mass production process for cultured red blood cells as a transfusion product.

Unknown
4 employees
Enduro vs

Quantoom Biosciences is reinventing mRNA production by developing an RNA Platform (Nfinity™) that en...

124 employees
Enduro vs

Bioengineers from Lab to Plants

81 employees
Biotechnology
Also compare with: Enduro vs TreeFrog Therapeutics TreeFrog Therapeutics

FAQ About Enduro

Bioproduction at scale
Enduro was founded in 2019.
Enduro is headquartered in Denmark.
Enduro operates in the following industries: Biotechnology.
Enduro has approximately 25 employees.
Enduro has completed 4 funding rounds, raising a total of $14.29M. The latest funding stage is Series A.
Top alternatives and competitors to Enduro include EryPharm, Quantoom Biosciences, Bioengineering AG, TreeFrog Therapeutics, MagGenix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Enduro and EryPharm are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Enduro and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy